Pages that link to "Q39101995"
Jump to navigation
Jump to search
The following pages link to Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians (Q39101995):
Displaying 50 items.
- Omega-3 fatty acids for the treatment of dementia (Q24185910) (← links)
- Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia (Q24235324) (← links)
- Almitrine-Raubasine combination for dementia (Q24235696) (← links)
- Almitrine-Raubasine combination for dementia (Q24241067) (← links)
- A practical algorithm for managing Alzheimer's disease: what, when, and why? (Q26859831) (← links)
- Practical diagnosis and management of dementia due to Alzheimer's disease in the primary care setting: an evidence-based approach (Q27006895) (← links)
- Brain Anatomy in Latino Farmworkers Exposed to Pesticides and Nicotine (Q28394205) (← links)
- Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study (Q28476190) (← links)
- Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy. (Q30234535) (← links)
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence (Q33165693) (← links)
- The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease (Q33165801) (← links)
- Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. (Q33415119) (← links)
- Clinical practice with antidementia and antipsychotic drugs: Audit from a geriatric clinic in India (Q33574426) (← links)
- Update on the Pharmacological Treatment of Alzheimers Disease (Q33836947) (← links)
- A drug utilization study of cognition enhancers in dementia in a tertiary care hospital in mumbai (Q33839610) (← links)
- Drugs for Alzheimer's disease: are they effective? (Q33865325) (← links)
- Optimal management of Alzheimer's disease patients: Clinical guidelines and family advice (Q33881534) (← links)
- Alzheimer's disease: a healthcare burden of epidemic proportion (Q33932371) (← links)
- Quality of dementia clinical guidelines and relevance to the care of older people with comorbidity: evidence from the literature (Q34090081) (← links)
- Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes (Q34231952) (← links)
- A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease (Q34318028) (← links)
- Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease (Q34327769) (← links)
- Current and future treatments for Alzheimer's disease (Q34646921) (← links)
- Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews (Q34704481) (← links)
- Economic analysis of opportunities to accelerate Alzheimer's disease research and development (Q34852407) (← links)
- Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease (Q35006354) (← links)
- Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications (Q35197111) (← links)
- Predictors of sustained response to rivastigmine in patients with Alzheimer's disease: a retrospective analysis (Q35252005) (← links)
- Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial (Q35276747) (← links)
- Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression (Q35332241) (← links)
- Posterior Teeth Occlusion Associated with Cognitive Function in Nursing Home Older Residents: A Cross-Sectional Observational Study (Q35825889) (← links)
- The Relationship between Obesity and the High Probability of Dementia Based on the Body Mass Index and Waist Circumference (Q36058674) (← links)
- Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations (Q36174613) (← links)
- Increasing value and reducing waste in research design, conduct, and analysis (Q36420861) (← links)
- Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System (Q36534889) (← links)
- Structured approach to patients with memory difficulties in family practice (Q36680461) (← links)
- Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions (Q36799847) (← links)
- Cholinesterase Inhibitor and Memantine Use in Newly Admitted Nursing Home Residents with Dementia (Q36826416) (← links)
- Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai (Q36830837) (← links)
- Pharmacotherapeutic management of dementia across settings of care (Q36849968) (← links)
- Assessing care of vulnerable elders--Alzheimer's disease: a pilot study of a practice redesign intervention to improve the quality of dementia care (Q36887279) (← links)
- Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures (Q36961194) (← links)
- Improving the relevance and consistency of outcomes in comparative effectiveness research (Q37050937) (← links)
- Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia (Q37316293) (← links)
- Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease (Q37337050) (← links)
- Alzheimer's disease drug development: old problems require new priorities (Q37363992) (← links)
- Disease-modifying drugs in Alzheimer's disease (Q37390739) (← links)
- Treatment of Alzheimer's disease in the long-term-care setting (Q37472650) (← links)
- Memantine: a review of its use in moderate to severe Alzheimer's disease (Q37863082) (← links)
- Cerebrolysin: a review of its use in dementia (Q37619494) (← links)